LNR SRL
LNR reported total assets of 516,544 € at the end of the 2025 financial year (annual accounts filed with the NBB on 13 Jan 2026).
The score of LNR shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +32 % Total assets +37 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
LNR's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 47,987 € | ||||
| Equity | 445,506 € | ||||
| Cash | 299,652 € | ||||
| EBITDA | 80,229 € | ||||
| Total assets | 516,544 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Jan 2026
- Year ended 31 Dec 2024filed on 03 Apr 2025
- Year ended 31 Dec 2023filed on 03 Jun 2024
- Year ended 31 Dec 2022filed on 30 May 2023
- Year ended 31 Dec 2021filed on 10 Jun 2022
LNR's financial analysis
- Solvency86.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of LNR
LNR's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0888.288.881
- VAT number
- BE0888288881
- Peppol
- Registered · 0208:0888288881 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Mar 2007
- Registered office
- 2460 Kasterlee
- Latest accounts
- 2025 · filed on 13 Jan 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
LNR (SRL) has been based in Kasterlee since 2007, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 47,987 € and equity of 445,506 €; its revenue is not published. Its solvency stands at 86.2%, above the median of its sector (44.2%).
Companies similar to LNR
Companies in the same business, of comparable size and area, outside its group.
- Apotheek De Vijzel Retail sale of pharmaceutical products Zoersel · balance sheet 509,493 €
- Marc Thoné Retail sale of pharmaceutical products Antwerp · balance sheet 93,815 €
- Pharmacie Delaunoy Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 522,244 €
- P.J. VLEUGELS et Cie Retail sale of pharmaceutical products Frameries · balance sheet 558,880 €
- ML Pharma Retail sale of pharmaceutical products Brussels · balance sheet 573,903 €
- Medicuro Retail sale of pharmaceutical products Stekene · balance sheet 457,159 €
- Smets Pharma Retail sale of pharmaceutical products Lier · balance sheet 452,862 €
- Biloba Kessel-LO Retail sale of pharmaceutical products Leuven · balance sheet 611,082 €
Frequently asked questions about LNR
What is the revenue of LNR?
LNR files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of LNR?
In Belgium, the VAT number is the company number prefixed with BE: BE0888288881 for LNR, if the company is VAT-registered. Its company number (CBE) is 0888.288.881.
Where is the registered office of LNR?
According to the CBE register, the registered office of LNR is in 2460 Kasterlee.
What is the equity of LNR?
At the close of the 2025 financial year, the equity of LNR amounts to 445,506 €, a solvency of 86.2% of total assets.
Who manages LNR?
The register lists 2 active mandates at LNR. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of LNR
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →